重组小鼠TREML2(TLT-2)(髓细胞触发受体样蛋白2)

特别提示：包括重组小鼠TREML2(TLT-2)(髓细胞触发受体样蛋白2)在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组小鼠TREML2(TLT-2)(髓细胞触发受体样蛋白2)
英文名称：Recombinant Mouse Triggering Receptor Expressed on Myeloid Cells-like Protein 2
产品货号：JN1515
产品规格：10μg|50μg|500μg|1mg

本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的His25-Ala270在C端含有His标签。

TREML2/TLT-2质量控制：＞95%(还原性SDS-PAGE)

TREML2/TLT-2制剂：冻干品

TREML2/TLT-2保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

TREML2/TLT-2复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于TREML2/TLT-2：
Trem-like transcript 2 protein (TLT2), also known as Triggering receptor expressed on myeloid cells-like protein 2, TLT2 and C6orf76, is single-pass type I membrane protein. TREML2 contains one Ig-like V-type domain, which can be induced in CD4 T-cell by concanavalin-A. As a cell surface receptor, TREML2 may play a role in the innate and adaptive immune response. TREML2 also acts as a counter-receptor for CD276 and interaction with CD276 on T-cells enhances T-cell activation. It has shown that TREML2 may be involved in the innate immune response based on its expression profile and the fact that it is up-regulated in response to inflammation.

我公司销售的重组小鼠TREML2(TLT-2)(髓细胞触发受体样蛋白2)，重组Triggering Receptor Expressed on Myeloid Cells-like Protein 2，rTREML2，Recombinant Mouse Triggering Receptor Expressed on Myeloid Cells-like Protein 2，重组小鼠TREML2，rmTLT-2，重组小鼠髓细胞触发受体样蛋白2，重组小鼠TLT-2，重组髓细胞触发受体样蛋白2，rmTREML2，rTLT-2，重组TLT-2，重组TREML2，重组小鼠Triggering Receptor Expressed on Myeloid Cells-like Protein 2质量上佳，价格普惠，欢迎广大新老客户踊跃订购。